2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Esophagus Cancer Surgery
Esophageal cancer surgery is a critical aspect of cancer treatment, particularly for advanced cases where other therapies may not be as effective. Surgeons often perform esophagectomy, removing the cancerous part of the esophagus and sometimes nearby lymph nodes. Minimally invasive techniques like laparoscopy or robotic surgery are increasingly utilized, reducing recovery time and complications.
Research in this field focuses on refining surgical approaches to enhance outcomes and minimize post-operative complications. Innovations such as targeted therapies, precision medicine, and advancements in imaging technologies aid in early detection and personalized treatment plans. Additionally, interdisciplinary collaboration between surgeons, oncologists, and researchers drives progress in optimizing surgical techniques and improving patient survival rates. Continuous research efforts aim to refine esophageal cancer surgery, offering better prognosis and quality of life for patients battling this challenging disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China